Index RUT P/E 53.66 EPS (ttm) 0.09 Insider Own 2.84% Shs Outstand 307.03M Perf Week -10.12%
Market Cap 1.55B Forward P/E 63.25 EPS next Y 0.08 Insider Trans -3.75% Shs Float 298.36M Perf Month -5.42%
Enterprise Value 1.52B PEG 2.14 EPS next Q 0.01 Inst Own 55.56% Short Float 7.71% Perf Quarter 32.81%
Income 29.23M P/S 4.95 EPS this Y -10.00% Inst Trans -2.33% Short Ratio 4.81 Perf Half Y 15.79%
Sales 313.79M P/B - EPS next Y -11.11% ROA 6.10% Short Interest 23.01M Perf YTD -21.31%
Book/sh -0.15 P/C 5.98 EPS next 5Y 25.09% ROE - 52W High 7.44 -31.99% Perf Year -28.53%
Cash/sh 0.85 P/FCF 36.35 EPS past 3/5Y - - ROIC 22.07% 52W Low 3.38 49.65% Perf 3Y 31.09%
Dividend Est. - EV/EBITDA 17.49 Sales past 3/5Y 55.84% 35.27% Gross Margin 75.18% Volatility 5.76% 5.12% Perf 5Y 107.38%
Dividend TTM - EV/Sales 4.84 EPS Y/Y TTM 24.15% Oper. Margin 24.32% ATR (14) 0.29 Perf 10Y -64.74%
Dividend Ex-Date - Quick Ratio 3.04 Sales Y/Y TTM 17.44% Profit Margin 9.32% RSI (14) 40.80 Recom 1.00
Dividend Gr. 3/5Y - - Current Ratio 3.29 EPS Q/Q -36.95% SMA20 -7.27% Beta 0.83 Target Price 9.44
Payout 0.00% Debt/Eq - Sales Q/Q 17.20% SMA50 -6.80% Rel Volume 0.72 Prev Close 5.07
Employees 407 LT Debt/Eq - Earnings Nov 05 BMO SMA200 6.30% Avg Volume 4.79M Price 5.06
IPO Jul 28, 2004 Option/Short Yes / Yes EPS/Sales Surpr. 59.57% 2.35% Trades
Volume 3,460,551 Change -0.20%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-13-25 Initiated Leerink Partners
Outperform
$7
Oct-20-25 Initiated Wells Fargo
Overweight
$10
Oct-10-25 Initiated Leerink Partners
Outperform
$9
Jul-16-25 Resumed H.C. Wainwright
Buy
$9
Apr-10-25 Initiated Mizuho
Outperform
$12
Feb-10-25 Initiated Wedbush
Outperform
$11
Dec-20-24 Initiated Wells Fargo
Overweight
$9
Dec-19-24 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$7 → $10
Sep-09-24 Resumed Leerink Partners
Outperform
$7 → $8
Jun-13-24 Initiated Rodman & Renshaw
Buy
$8
Oct-10-23 Initiated Wedbush
Outperform
$10
May-14-21 Initiated RBC Capital Mkts
Sector Perform
$5
Dec-24-19 Initiated Oppenheimer
Outperform
$2.50
Oct-25-19 Initiated Cantor Fitzgerald
Overweight
$3
May-14-19 Initiated BTIG Research
Buy
$3
Mar-04-19 Initiated SVB Leerink
Outperform
$3
Feb-22-19 Initiated SVB Leerink
Outperform
$3
Feb-28-18 Downgrade Maxim Group
Hold → Sell
$1
Nov-01-17 Downgrade Maxim Group
Buy → Hold
Oct-10-17 Initiated H.C. Wainwright
Buy
$7
Show Previous Ratings
Nov-11-25 04:05PM
Nov-10-25 08:00AM
Nov-08-25 12:00PM
Nov-06-25 09:00AM
Nov-05-25 09:30AM
09:15AM
Loading…
09:15AM
08:08AM
(Associated Press Finance)
08:00AM
Nov-04-25 07:56AM
Oct-30-25 10:00AM
Oct-29-25 04:05PM
Oct-13-25 08:05AM
Oct-07-25 09:00AM
Sep-29-25 06:05AM
Sep-10-25 11:30AM
10:30AM
Loading…
Sep-02-25 10:30AM
(Associated Press Finance) +25.05%
Aug-31-25 12:16AM
Aug-29-25 09:38AM
05:10AM
Aug-27-25 04:05PM
08:05AM
04:46AM
Aug-25-25 11:56PM
07:30AM
Aug-22-25 11:45PM
Aug-17-25 06:26PM
Aug-06-25 09:30AM
08:25AM
07:10AM
07:05AM
09:56AM
Loading…
Aug-05-25 09:56AM
Aug-04-25 10:01AM
Aug-01-25 06:46AM
Jul-31-25 10:00AM
Jul-30-25 04:05PM
10:00AM
Jul-28-25 02:27AM
Jul-23-25 11:25AM
Jul-17-25 11:11AM
Jul-11-25 11:28AM
Jul-07-25 09:10AM
Jun-25-25 09:28AM
Jun-24-25 03:52PM
Jun-23-25 12:16PM
Jun-09-25 04:05PM
May-27-25 09:15AM
May-13-25 04:05PM
May-09-25 10:31AM
May-08-25 09:25AM
08:21AM
(Associated Press Finance)
08:05AM
May-07-25 12:32PM
10:12AM
May-05-25 04:06PM
May-01-25 04:05PM
Apr-18-25 10:00AM
Apr-16-25 11:17AM
Apr-07-25 12:30PM
Mar-10-25 06:05AM
Feb-27-25 02:19AM
12:30AM
Feb-26-25 07:30PM
06:15PM
05:08PM
(Associated Press Finance)
04:05PM
Feb-25-25 10:30AM
Feb-24-25 09:16AM
Feb-19-25 04:05PM
Feb-06-25 04:05PM
Jan-06-25 04:30PM
08:47AM
Dec-18-24 07:00AM
Dec-16-24 06:05AM
Dec-11-24 06:00AM
Nov-08-24 01:26PM
(Thomson Reuters StreetEvents)
02:28AM
Nov-07-24 11:15PM
07:00PM
05:40PM
04:34PM
(Associated Press Finance)
04:02PM
Nov-06-24 07:17AM
Nov-05-24 04:15PM
Nov-04-24 06:05AM
Nov-01-24 09:15AM
Oct-31-24 04:05PM
Oct-30-24 09:00PM
Oct-09-24 05:13PM
Oct-07-24 12:10PM
Oct-04-24 09:35AM
Sep-30-24 08:01AM
06:00AM
Sep-21-24 02:47AM
Sep-18-24 06:15AM
Sep-15-24 07:21PM
Sep-10-24 04:30PM
Sep-05-24 01:33AM
Aug-31-24 01:42AM
Aug-27-24 04:30PM
Aug-14-24 08:00AM
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Singh Sanjay R EVP Technical Operations Nov 14 '25 Sale 5.03 18,777 94,448 455,211 Nov 14 08:00 PM SANJAY SINGH Officer Nov 14 '25 Proposed Sale 5.03 18,777 94,493 Nov 14 04:02 PM Tross Stuart A Chief People & Workpl Officer Sep 16 '25 Sale 5.34 47,000 250,980 1,032,013 Sep 17 07:39 PM STUART A TROSS Officer Sep 16 '25 Proposed Sale 5.34 47,000 250,792 Sep 16 04:05 PM Binder Steven B. Director Jul 16 '25 Sale 3.94 75,367 296,946 830,508 Jul 17 08:51 PM Thomson David EVP Genl Counsel & Secretary Jul 16 '25 Sale 3.94 7,466 29,416 841,719 Jul 17 08:46 PM DAVID THOMSON Officer Jul 16 '25 Proposed Sale 3.94 7,466 29,427 Jul 16 04:10 PM STEVEN B BINDER Director Jul 16 '25 Proposed Sale 3.94 75,367 296,645 Jul 16 04:04 PM Binder Steven B. Director Jun 10 '25 Sale 4.00 64,085 256,340 925,258 Jun 10 08:07 PM STEVEN B BINDER Director Jun 10 '25 Proposed Sale 4.00 64,085 256,430 Jun 10 04:02 PM Binder Steven B. Director May 20 '25 Sale 4.40 12,078 53,143 989,343 May 20 09:45 PM Thomson David EVP Genl Counsel & Secretary May 20 '25 Sale 4.41 2,345 10,341 879,546 May 20 09:44 PM DAVID THOMSON Officer May 20 '25 Proposed Sale 4.41 2,345 10,334 May 20 04:14 PM STEVEN B BINDER Director May 20 '25 Proposed Sale 4.40 12,078 53,184 May 20 04:03 PM Thomson David EVP Genl Counsel & Secretary May 13 '25 Sale 4.68 32,179 150,598 772,427 May 15 09:37 PM Binder Steven B. Director May 13 '25 Sale 4.69 80,144 375,875 1,006,611 May 15 09:35 PM STEVEN B BINDER Director May 13 '25 Proposed Sale 4.69 80,144 375,499 May 13 04:03 PM DAVID THOMSON Officer May 13 '25 Proposed Sale 4.68 32,179 150,717 May 13 04:02 PM Binder Steven B. Director Nov 22 '24 Option Exercise 1.47 67,536 99,278 1,142,562 Nov 25 09:30 PM Binder Steven B. Director Nov 22 '24 Sale 6.89 67,536 465,323 1,075,026 Nov 25 09:30 PM STEVEN B BINDER Director Nov 22 '24 Proposed Sale 6.89 67,536 465,397 Nov 22 04:08 PM Binder Steven B. Director Nov 15 '24 Option Exercise 1.47 67,539 99,282 1,142,565 Nov 19 09:30 PM Binder Steven B. Director Nov 15 '24 Sale 6.76 67,539 456,564 1,075,026 Nov 19 09:30 PM STEVEN B BINDER Officer Nov 15 '24 Proposed Sale 6.76 67,539 456,793 Nov 15 04:01 PM
